Tissue Plasminogen Activator Non-Treatment in First-Time Ischemic Stroke

2.50
Hdl Handle:
http://hdl.handle.net/10755/338299
Category:
Full-text
Type:
Presentation
Title:
Tissue Plasminogen Activator Non-Treatment in First-Time Ischemic Stroke
Author(s):
Brewer, Will E.
Lead Author STTI Affiliation:
Upsilon Omicron
Author Details:
Will E. Brewer, MSN, RN, CEN, brewerw@uab.edu
Abstract:
Session presented on Friday, September 26, 2014: Purpose/Background: Strokes are a significant problem in America; as about every 40 seconds someone experiences a stroke. Eighty-seven percent of all cerebrovascular events are ischemic in origin and could possibly be treated with tissue plasminogen activator (tPA). However, whether at a stroke certified organization or a small community hospital, tPAs use is extremely conservative. Since its inception, the use of tPA has been controversial among cerebrovascular and emergency clinicians. However, it remains the most timely and conventional treatment for acute ischemic stroke. The purpose of this proposed qualitative research study is to evaluate physicians attitudes toward tPA and how their attitudes negate its use in first-time ischemic stroke treatment. Research Questions: (a) What are physicians attitudes toward tPA usage in first time ischemic stroke? (b) How do physicians describe their comfort level in prescribing tPA in a first-time stroke victim? (c) Does the unfamiliarity/non-use of tPA among physicians lead them to apply a non-credible exclusion criteria to the decision process? Sample/Methodology: Descriptive phenomenology will be utilized to examine why physicians underutilize tPA as a treatment modality for first-time ischemic stroke. The lived experiences of the physicians are incredibly valuable in this proposed research study. The sample for this proposed study will include emergency department physicians from various medical centers in Alabama. Focused interviews will be employed to collect research information. Theoretical Framework: Dr. Albert Banduras social cognitive theory will guide the research study. In Banduras theory, he described human beings as adaptive learners. The model is based upon three areas: cognitive/personal, behavioral, and environmental. These three domains compose the triadic reciprocal causation and states that each area is interchangeable. Essentially, Bandura found that humans learn behavior by watching and learning from others. Have physicians learned negative behaviors about tPA from their mentors and continue to use them in their own practice? One of the strongest driving forces is behavior. Just one adverse outcome from tPA can haunt the clinician and negate its use for years to come.
Keywords:
Tissue Plasminogen Activator; Ischemic Stroke
Repository Posting Date:
15-Jan-2015
Date of Publication:
15-Jan-2015
Other Identifiers:
LEAD14PST89
Conference Date:
2014
Conference Name:
Leadership Summit 2014
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Indianapolis, Indiana, USA
Description:
Leadership Summit 2014 Theme: Personal. Professional. Global. Held at the Indianapolis Marriott Downtown, Indianapolis.
Note:
Items submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Henderson Repository.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.typePresentationen
dc.titleTissue Plasminogen Activator Non-Treatment in First-Time Ischemic Strokeen_US
dc.contributor.authorBrewer, Will E.en
dc.contributor.departmentUpsilon Omicronen
dc.author.detailsWill E. Brewer, MSN, RN, CEN, brewerw@uab.eduen
dc.identifier.urihttp://hdl.handle.net/10755/338299-
dc.description.abstractSession presented on Friday, September 26, 2014: Purpose/Background: Strokes are a significant problem in America; as about every 40 seconds someone experiences a stroke. Eighty-seven percent of all cerebrovascular events are ischemic in origin and could possibly be treated with tissue plasminogen activator (tPA). However, whether at a stroke certified organization or a small community hospital, tPAs use is extremely conservative. Since its inception, the use of tPA has been controversial among cerebrovascular and emergency clinicians. However, it remains the most timely and conventional treatment for acute ischemic stroke. The purpose of this proposed qualitative research study is to evaluate physicians attitudes toward tPA and how their attitudes negate its use in first-time ischemic stroke treatment. Research Questions: (a) What are physicians attitudes toward tPA usage in first time ischemic stroke? (b) How do physicians describe their comfort level in prescribing tPA in a first-time stroke victim? (c) Does the unfamiliarity/non-use of tPA among physicians lead them to apply a non-credible exclusion criteria to the decision process? Sample/Methodology: Descriptive phenomenology will be utilized to examine why physicians underutilize tPA as a treatment modality for first-time ischemic stroke. The lived experiences of the physicians are incredibly valuable in this proposed research study. The sample for this proposed study will include emergency department physicians from various medical centers in Alabama. Focused interviews will be employed to collect research information. Theoretical Framework: Dr. Albert Banduras social cognitive theory will guide the research study. In Banduras theory, he described human beings as adaptive learners. The model is based upon three areas: cognitive/personal, behavioral, and environmental. These three domains compose the triadic reciprocal causation and states that each area is interchangeable. Essentially, Bandura found that humans learn behavior by watching and learning from others. Have physicians learned negative behaviors about tPA from their mentors and continue to use them in their own practice? One of the strongest driving forces is behavior. Just one adverse outcome from tPA can haunt the clinician and negate its use for years to come.en
dc.subjectTissue Plasminogen Activatoren
dc.subjectIschemic Strokeen
dc.date.available2015-01-15T13:35:00Z-
dc.date.issued2015-01-15-
dc.date.accessioned2015-01-15T13:35:00Z-
dc.conference.date2014en
dc.conference.nameLeadership Summit 2014en
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen
dc.conference.locationIndianapolis, Indiana, USAen
dc.descriptionLeadership Summit 2014 Theme: Personal. Professional. Global. Held at the Indianapolis Marriott Downtown, Indianapolis.en
dc.description.noteItems submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Henderson Repository.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.